Fernando Gomes de Almeida
Fernando Gomes de Almeida has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Ernesto Díaz Rocha
Faculdade de Farmácia Universidade Federal do Rio de Janeiro Rio de Janeiro Brazil
2 shared publications - Virgínia Martins Carvalho
Faculdade de Farmácia Universidade Federal do Rio de Janeiro Rio de Janeiro Brazil
2 shared publications - Ana Cláudia de Macêdo Vieira
Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
1 shared publication Andrey de Aguiar
1 shared publication- Antonio Jorge Ribeiro da Silva
Natural Products Research Institute (IPPN), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
1 shared publication Fernanda Pereira
1 shared publication
Latest Publications
- Open Access
- 2 October 2026
- Published by Pro Reitoria de Pesquisa, Pos Graduacao e Inovacao - UFF in Neurociências & Sociedade
- Vol. 3 (1) , e026006
A face "Janus" dos canabinoides sintéticos
Os canabinoides sintéticos (CS) surgiram originalmente como ferramentas farmacológicas para o estudo dos efeitos da Cannabis e do Sistema Endocanabinoide, mas foram incorporados pelo mercado ilícito para uso recreativo e transformados em potentes drogas de abuso. Comercializados em diversas apresentações e sob nomenclaturas populares variadas, essas substâncias possuem elevada potência e toxicidade, podendo provocar efeitos adversos graves e multissistêmicos, e desafiando as instituições de saúde e segurança. O presente artigo aborda essa dualidade dos CS, revisando sua evolução histórica, características químicas, formas de consumo e impactos fisiológicos e toxicológicos, com foco no Sistema Nervoso, além do panorama regulatório e epidemiológico no Brasil. Embora permaneçam relevantes como ferramentas de pesquisa científica e por seu potencial terapêutico, os CS representam uma importante ameaça à saúde pública quando utilizados como drogas recreativas. Nesse cenário, a integração entre setores científicos, regulatórios, de segurança, de saúde e de educação pública torna-se fundamental para acompanhar a rápida transformação dessas substâncias e reduzir seus impactos sobre a sociedade.
- 2 October 2026
- Published by Pro Reitoria de Pesquisa, Pos Graduacao e Inovacao - UFF in Neurociências & Sociedade
- Vol. 3 (1) , e026006
Open AccessA face "Janus" dos canabinoides sintéticos
Os canabinoides sintéticos (CS) surgiram originalmente como ferramentas farmacológicas para o estudo dos efeitos da Cannabis e do Sistema Endocanabinoide, mas foram incorporados pelo mercado ilícito para uso recreativo e transformados em potentes drogas de abuso. Comercializados em diversas apresentações e sob nomenclaturas populares variadas, essas substâncias possuem elevada potência e toxicidade, podendo provocar efeitos adversos graves e multissistêmicos, e desafiando as instituições de saúde e segurança. O presente artigo aborda essa dualidade dos CS, revisando sua evolução histórica, características químicas, formas de consumo e impactos fisiológicos e toxicológicos, com foco no Sistema Nervoso, além do panorama regulatório e epidemiológico no Brasil. Embora permaneçam relevantes como ferramentas de pesquisa científica e por seu potencial terapêutico, os CS representam uma importante ameaça à saúde pública quando utilizados como drogas recreativas. Nesse cenário, a integração entre setores científicos, regulatórios, de segurança, de saúde e de educação pública torna-se fundamental para acompanhar a rápida transformação dessas substâncias e reduzir seus impactos sobre a sociedade.
- 2 June 2023
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 33 (4) , 724-735
Pharmaceutical Evaluation of Medical Cannabis Extracts Prepared by Artisanal and Laboratory Techniques
- 2 June 2023
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 33 (4) , 724-735
Pharmaceutical Evaluation of Medical Cannabis Extracts Prepared by Artisanal and Laboratory Techniques
- 23 June 2021
- Published by Brazilian Journal of Analytical Chemistry in Brazilian Journal of Analytical Chemistry
- Vol. 9 (34) , 162-176
Facing the Forensic Challenge of Cannabis Regulation: A Methodology for the Differentiation between Hemp and Marijuana Samples / Presumptive and confirmatory methods for hemp and marijuana analysis
Access to medical and recreational cannabis has been regulated in several countries. Cannabinoids are secondary metabolites used as chemical markers of Cannabis genus plants. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the most abundant cannabinoids and their proportion is used to differentiate hemp (THC/CBD1) varieties. Brazilian sanitary regulations permit prescription, importation and sale of cannabis-derived products by pharmaceuticals distributors and drugstores, even though their crops are still prohibited, and the current scenario is characterized by marijuana trafficking, legal trade of medical cannabis products, and cultivation and production of cannabis-derived products by patients and non-governmental organizations (NGOs), with or without judicial authorizations. Medical cannabis regulation is in progress and there is an urgent need to implement analytical methods for monitoring the chemical profile of cannabis crops. Thus, the goal of the present study was to propose a methodology based on presumptive and confirmatory methods to differentiate the two principal chemovars of Cannabis genus plants, i.e., CBD-rich (hemp) and THC-rich (marijuana). A color test and a validated high-performance liquid chromatography (HPLC) method were applied to six cannabis samples cultivated by patients with judicial authorization. The methodology proved to be useful for forensic purposes and for quality control of medical cannabis. Plants cultivated by patients showed three profiles, classified as THC-rich, CBD-rich and approximately 1:1 THC/CBD ratio.
- 23 June 2021
- Published by Brazilian Journal of Analytical Chemistry in Brazilian Journal of Analytical Chemistry
- Vol. 9 (34) , 162-176
Facing the Forensic Challenge of Cannabis Regulation: A Methodology for the Differentiation between Hemp and Marijuana Samples / Presumptive and confirmatory methods for hemp and marijuana analysis
Access to medical and recreational cannabis has been regulated in several countries. Cannabinoids are secondary metabolites used as chemical markers of Cannabis genus plants. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the most abundant cannabinoids and their proportion is used to differentiate hemp (THC/CBD1) varieties. Brazilian sanitary regulations permit prescription, importation and sale of cannabis-derived products by pharmaceuticals distributors and drugstores, even though their crops are still prohibited, and the current scenario is characterized by marijuana trafficking, legal trade of medical cannabis products, and cultivation and production of cannabis-derived products by patients and non-governmental organizations (NGOs), with or without judicial authorizations. Medical cannabis regulation is in progress and there is an urgent need to implement analytical methods for monitoring the chemical profile of cannabis crops. Thus, the goal of the present study was to propose a methodology based on presumptive and confirmatory methods to differentiate the two principal chemovars of Cannabis genus plants, i.e., CBD-rich (hemp) and THC-rich (marijuana). A color test and a validated high-performance liquid chromatography (HPLC) method were applied to six cannabis samples cultivated by patients with judicial authorization. The methodology proved to be useful for forensic purposes and for quality control of medical cannabis. Plants cultivated by patients showed three profiles, classified as THC-rich, CBD-rich and approximately 1:1 THC/CBD ratio.